Nashville Biosciences is a clinical big data & genomics
company accelerating the R&D activity of partners in the
biopharmaceutical, diagnostics, and AI industries.

 

Keep In Touch

GeoWolf brings new possibilities
for staying connected with friends.

WHO WE ARE

Our History

Genomics is one of the fastest developing research areas in the world today. Due to rapid advancements, in-depth genetic analysis has become essential in R&D and clinical practice.

With drug development costs forecast to double every nine years, we need more than ever to improve R&D productivity and uncover new ways to diagnose and care for diseases more efficiently. In order to increase the speed-to-market for life sciences companies, it’s imperative that we fully recognize and capture the potential of human genetics in drug and diagnostics R&D.

Understanding the Complex Relationship Between Genes and Disease

At Nashville Biosciences, we are gaining valuable genetic insights through BioVU®, a biobank of millions of longitudinal medical records spanning over 10 years with hundreds of thousands of matched genetic samples. Created at Vanderbilt University Medical Center and Vanderbilt University, BioVU® is a biorepository of DNA extracted from discarded blood collected during routine clinical testing. Through the use of Nashville Biosciences’ advanced technology and novel algorithms, the team is discovering important genetic associations and identifying genes that contribute to help advance the R&D efforts of our partners.

Transforming the DNA of Life Science Research and Development

As a subsidiary of Vanderbilt University Medical Center, Nashville Biosciences is partnering with the healthcare industry to leverage the power of BioVU® and provide unparalleled clinical insight, resources, and expertise to a wide range of R&D challenges.

OUR PEOPLE

Meet the Team

The Nashville Biosciences team is comprised of industry veterans, physicians and scientists dedicated to serving our clients.

Leeland Ekstrom, Ph.D

Founder & Chief Operating Officer

James Stover, Ph.D.

Chief Business Officer

Judsen Schneider, Ph.D.

Chief Technology Officer

Karen Nanney

Secretary, Treasurer & Chief Financial Officer

Steven Held, MD

Medical Director

Phil LoCascio, PhD

Senior Computational Biologist

Kai Smith

Application Developer

Erin Sundaram, PhD

Senior Genomic Scientist

Lakshmi Sundarajan, PhD

Genomic Scientist

Ed Uberbacher, Ph.D.

Director of Bioinformatics

Jamie Wenke, Ph.D.

Senior Genomics Scientist

Yiyang Wu, MD, Ph.D.

Genomics Scientist

Joanne Johnson

Office Manager

Shanon Simons, CPA

Director of Finance and Controller

Hero Wu, Canine PhD

Office Mascot

Jon Duane, M.B.A.

Executive Chairman
Senior Partner Emeritus, McKinsey & Company

Gordon R. Bernard, M.D.

Melinda Owen Bass Professor of Medicine, EVP for Research and Director of Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center

Sam Lynch, D.M.D., D.M.Sc.

President and CEO, Lynch Biologics; Immediate Past Chairman, Life Sciences Tennessee

John F. Manning, Jr., Ph.D., M.B.A.

Chief Operating Officer and Corporate Chief of Staff, Vanderbilt University Medical Center

Susan R. Wente, Ph.D.

Provost and Vice Chancellor for Academic Affairs, Professor of Cell and Developmental Biology, Vanderbilt University

VANDERBILT SCIENTIFIC ADVISORS

Dan M. Roden, M.D.C.M.

Director, Oates Institute for Experimental Therapeutics
Assistant Vice Chancellor for Personalized Medicine
Sam Clark Professor of Experimental Therapeutics
Professor of Medicine & Pharmacology
Vanderbilt University Medical Center

Joshua C. Denny, M.D., M.S.

Director, Center for Precision Medicine
Professor of Medicine & Biomedical Informatics
Vanderbilt University Medical Center

Nancy J. Cox, Ph.D.

Mary Phillips Edmonds Gray Professor of Genetics
Professor of Medicine
Director, Vanderbilt Genetics Institute
Director, Division of Genetic Medicine
Vanderbilt University Medical Center

Lawrence J. Marnett, PhD.

Dean of Basic Sciences, School of Medicine
Mary Geddes Stahlman Professor of Cancer Research
Director, A.B. Hancock Jr. Memorial Laboratory
Professor of Biochemistry, Chemistry and Pharmacology
Vanderbilt University

OUR PROMISE

Unwavering Commitment to Patient Privacy

Patient welfare is a top priority for Nashville Biosciences and as such, we are committed to transparency in our practices and ensuring the protection of patient data.

Prior to any blood test, patients are provided with information about BioVU®, its research and goals. After learning about the program, patients are presented with a consent form in which they can either choose to donate their leftover blood sample or decline to participate. If a patient does not want to donate any leftover samples to BioVU®, they simply do not sign the form. If a patient consents to share his or her leftover samples with BioVU® and is a match for current research programs, BioVU® removes all personally identifiable information from the sample and medical record, then stores it in a safe and secure location. Additionally, if a patient changes their mind after signing the BioVU® consent form, they can call a BioVU® helpline to withdraw their participation from any future research.

Nashville Biosciences, Vanderbilt University Medical Center, and BioVU® regularly engage experts in ethics, science and research, operations, data security, and patient advocacy, among others, to ensure the accessibility and transparency of our information and to inform engagement with all stakeholders, including patients.

Publications